KALEIDO BIOSCIENCES, INC. Operating Income
KALEIDO BIOSCIENCES, INC. reported Operating Income of -$87.67 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-04-01
- KALEIDO BIOSCIENCES, INC. operating income (loss) for the quarter ending 2021-12-31 was -$19.70M.
- KALEIDO BIOSCIENCES, INC. operating income (loss) for the quarter ending 2021-09-30 was -$22.41M.
- KALEIDO BIOSCIENCES, INC. operating income (loss) for the quarter ending 2021-06-30 was -$23.21M.
- KALEIDO BIOSCIENCES, INC. operating income (loss) for the quarter ending 2021-03-31 was -$22.35M.
- KALEIDO BIOSCIENCES, INC. operating income (loss) for fiscal 2021 was -$87.67M.
- KALEIDO BIOSCIENCES, INC. operating income (loss) for fiscal 2020 was -$78.87M.
- KALEIDO BIOSCIENCES, INC. operating income (loss) for fiscal 2019 was -$86.66M.
- KALEIDO BIOSCIENCES, INC. operating income (loss) for fiscal 2018 was -$60.68M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$19.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | -$42.11M derived: sum of 2 quarters · filed 2022-04-01 | -$65.32M derived: sum of 3 quarters · filed 2022-04-01 | -$87.67M 10-K · filed 2022-04-01 |
| 2021-09-30 | -$22.41M 10-Q · filed 2021-11-01 | -$45.62M derived: sum of 2 quarters · filed 2021-11-01 | -$67.97M 10-Q · filed 2021-11-01 | -$87.27M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-06-30 | -$23.21M 10-Q · filed 2021-08-11 | -$45.55M 10-Q · filed 2021-08-11 | -$64.86M derived: sum of 3 quarters · filed 2022-04-01 | -$87.23M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-03-31 | -$22.35M 10-Q · filed 2021-05-04 | -$41.65M derived: sum of 2 quarters · filed 2022-04-01 | -$64.03M derived: sum of 3 quarters · filed 2022-04-01 | -$82.17M derived: sum of 4 quarters · filed 2022-04-01 |
| 2020-12-31 | -$19.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | -$41.68M derived: sum of 2 quarters · filed 2022-04-01 | -$59.82M derived: sum of 3 quarters · filed 2022-04-01 | -$78.87M 10-K · filed 2022-04-01 |
| 2020-09-30 | -$22.38M 10-Q · filed 2021-11-01 | -$40.52M derived: sum of 2 quarters · filed 2021-11-01 | -$59.57M 10-Q · filed 2021-11-01 | -$78.55M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | -$18.14M 10-Q · filed 2021-08-11 | -$37.20M 10-Q · filed 2021-08-11 | -$56.17M derived: sum of 3 quarters · filed 2021-08-11 | -$78.28M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$19.05M 10-Q · filed 2021-05-04 | -$38.02M derived: sum of 2 quarters · filed 2021-05-04 | -$60.14M derived: sum of 3 quarters · filed 2021-05-04 | -$85.10M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | -$18.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$41.09M derived: sum of 2 quarters · filed 2021-03-03 | -$66.05M derived: sum of 3 quarters · filed 2021-03-03 | -$86.66M 10-K · filed 2021-03-03 |
| 2019-09-30 | -$22.12M 10-Q · filed 2020-11-02 | -$47.07M derived: sum of 2 quarters · filed 2020-11-02 | -$67.69M 10-Q · filed 2020-11-02 | -$88.49M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | -$24.96M 10-Q · filed 2020-08-04 | -$45.57M 10-Q · filed 2020-08-04 | -$66.38M derived: sum of 3 quarters · filed 2020-08-04 | -$83.69M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | -$20.61M 10-Q · filed 2020-05-14 | -$41.42M derived: sum of 2 quarters · filed 2020-05-14 | -$58.73M derived: sum of 3 quarters · filed 2020-05-14 | -$71.08M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$38.12M derived: sum of 2 quarters · filed 2020-03-02 | -$50.47M derived: sum of 3 quarters · filed 2020-03-02 | -$60.68M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$17.31M 10-Q · filed 2019-10-30 | -$29.66M derived: sum of 2 quarters · filed 2019-10-30 | -$39.88M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | -$12.35M 10-Q · filed 2019-08-01 | -$22.57M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | -$10.22M 10-Q · filed 2019-05-02 |